ArticleFrontiers in immunology2025

Trained autologous cytotoxic T-cells derived from PBMCs or splenocytes for immunotherapy of neuroblastoma.

Xiaofang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.